

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.27119725 |
| 2 | positive regulation by symbiont of host defense response (GO:0052509) | 4.84400384 |
| 3 | modulation by symbiont of host defense response (GO:0052031) | 4.84400384 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.84400384 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.84400384 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.84400384 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 4.84400384 |
| 8 | oligosaccharide catabolic process (GO:0009313) | 4.39127568 |
| 9 | respiratory burst (GO:0045730) | 4.29130408 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.22294681 |
| 11 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.93431303 |
| 12 | barbed-end actin filament capping (GO:0051016) | 3.92231225 |
| 13 | protein localization to endosome (GO:0036010) | 3.78910002 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 3.78502785 |
| 15 | response to peptidoglycan (GO:0032494) | 3.73656546 |
| 16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.70138469 |
| 17 | * glycosphingolipid catabolic process (GO:0046479) | 3.67882619 |
| 18 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.61864096 |
| 19 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.57012919 |
| 20 | positive regulation of interferon-alpha production (GO:0032727) | 3.51971201 |
| 21 | hyaluronan catabolic process (GO:0030214) | 3.48941559 |
| 22 | immunoglobulin mediated immune response (GO:0016064) | 3.48650444 |
| 23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.46558409 |
| 24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.46558409 |
| 25 | signal peptide processing (GO:0006465) | 3.37610712 |
| 26 | protein retention in ER lumen (GO:0006621) | 3.35902767 |
| 27 | regulation of interferon-alpha production (GO:0032647) | 3.35023043 |
| 28 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.32069520 |
| 29 | neutrophil activation (GO:0042119) | 3.30657467 |
| 30 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.30264729 |
| 31 | granulocyte activation (GO:0036230) | 3.29817071 |
| 32 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.27441704 |
| 33 | positive regulation of antigen processing and presentation (GO:0002579) | 3.26739477 |
| 34 | * glycolipid catabolic process (GO:0019377) | 3.22663384 |
| 35 | apoptotic cell clearance (GO:0043277) | 3.21429348 |
| 36 | myeloid cell activation involved in immune response (GO:0002275) | 3.17922615 |
| 37 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.14685574 |
| 38 | pinocytosis (GO:0006907) | 3.11410019 |
| 39 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.10088877 |
| 40 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.09053674 |
| 41 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.06355292 |
| 42 | regulation of antigen processing and presentation (GO:0002577) | 3.06010284 |
| 43 | adhesion of symbiont to host (GO:0044406) | 3.04514257 |
| 44 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.03836435 |
| 45 | protein maturation by protein folding (GO:0022417) | 3.02658905 |
| 46 | microglial cell activation (GO:0001774) | 3.02200888 |
| 47 | amyloid precursor protein catabolic process (GO:0042987) | 3.01671465 |
| 48 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.98340053 |
| 49 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.97180762 |
| 50 | response to host immune response (GO:0052572) | 2.97180762 |
| 51 | cell adhesion mediated by integrin (GO:0033627) | 2.94890960 |
| 52 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.94619595 |
| 53 | positive regulation of mast cell activation (GO:0033005) | 2.93139577 |
| 54 | regulation of mast cell degranulation (GO:0043304) | 2.90993748 |
| 55 | regulation of monocyte chemotaxis (GO:0090025) | 2.89465578 |
| 56 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.87920415 |
| 57 | negative regulation of mast cell activation (GO:0033004) | 2.86984895 |
| 58 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.86187922 |
| 59 | reactive oxygen species biosynthetic process (GO:1903409) | 2.85793254 |
| 60 | leukocyte aggregation (GO:0070486) | 2.85298320 |
| 61 | N-acetylneuraminate metabolic process (GO:0006054) | 2.84875668 |
| 62 | regulation of mononuclear cell migration (GO:0071675) | 2.83452958 |
| 63 | response to muramyl dipeptide (GO:0032495) | 2.81762685 |
| 64 | regulation of superoxide anion generation (GO:0032928) | 2.80550352 |
| 65 | positive regulation of leukocyte degranulation (GO:0043302) | 2.80492467 |
| 66 | membrane raft organization (GO:0031579) | 2.79151296 |
| 67 | * membrane lipid catabolic process (GO:0046466) | 2.78910938 |
| 68 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.77438723 |
| 69 | * sphingolipid catabolic process (GO:0030149) | 2.77413118 |
| 70 | regulation of mast cell activation (GO:0033003) | 2.76681908 |
| 71 | * ceramide catabolic process (GO:0046514) | 2.76661844 |
| 72 | basement membrane organization (GO:0071711) | 2.76482720 |
| 73 | decidualization (GO:0046697) | 2.75824271 |
| 74 | cellular response to interferon-beta (GO:0035458) | 2.74926991 |
| 75 | macrophage activation (GO:0042116) | 2.73899674 |
| 76 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.73362073 |
| 77 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.72759497 |
| 78 | regulation of early endosome to late endosome transport (GO:2000641) | 2.72319698 |
| 79 | virion attachment to host cell (GO:0019062) | 2.70812312 |
| 80 | adhesion of symbiont to host cell (GO:0044650) | 2.70812312 |
| 81 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.70454902 |
| 82 | positive regulation of mast cell degranulation (GO:0043306) | 2.70182525 |
| 83 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.70182525 |
| 84 | positive regulation of interferon-beta production (GO:0032728) | 2.68788829 |
| 85 | mannose metabolic process (GO:0006013) | 2.68613099 |
| 86 | neutrophil mediated immunity (GO:0002446) | 2.65467330 |
| 87 | regulation of extracellular matrix disassembly (GO:0010715) | 2.65072153 |
| 88 | negative regulation of interleukin-12 production (GO:0032695) | 2.64089627 |
| 89 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.63931732 |
| 90 | leukocyte mediated cytotoxicity (GO:0001909) | 2.63560276 |
| 91 | keratan sulfate catabolic process (GO:0042340) | 2.63532512 |
| 92 | superoxide anion generation (GO:0042554) | 2.63053150 |
| 93 | detection of molecule of bacterial origin (GO:0032490) | 2.62505507 |
| 94 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.61238088 |
| 95 | stress fiber assembly (GO:0043149) | 2.61003480 |
| 96 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.60987908 |
| 97 | pyrimidine-containing compound salvage (GO:0008655) | 2.60897921 |
| 98 | pyrimidine nucleoside salvage (GO:0043097) | 2.60897921 |
| 99 | positive regulation of receptor recycling (GO:0001921) | 2.60019447 |
| 100 | response to fungus (GO:0009620) | 2.59868933 |
| 101 | myeloid cell homeostasis (GO:0002262) | 2.59737641 |
| 102 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.59375834 |
| 103 | transferrin transport (GO:0033572) | 2.59342149 |
| 104 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.58316569 |
| 105 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.57494022 |
| 106 | natural killer cell mediated immunity (GO:0002228) | 2.57494022 |
| 107 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.56822199 |
| 108 | regulation of leukocyte degranulation (GO:0043300) | 2.56673358 |
| 109 | peptide catabolic process (GO:0043171) | 2.56182606 |
| 110 | phagosome maturation (GO:0090382) | 2.55917878 |
| 111 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.55868835 |
| 112 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.54027825 |
| 113 | type B pancreatic cell proliferation (GO:0044342) | 2.53277611 |
| 114 | amyloid precursor protein metabolic process (GO:0042982) | 2.52602775 |
| 115 | COPI coating of Golgi vesicle (GO:0048205) | 2.51488193 |
| 116 | Golgi transport vesicle coating (GO:0048200) | 2.51488193 |
| 117 | actin nucleation (GO:0045010) | 2.51421862 |
| 118 | leukocyte degranulation (GO:0043299) | 2.51413420 |
| 119 | lipoxygenase pathway (GO:0019372) | 2.51041926 |
| 120 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.50651003 |
| 121 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.50554615 |
| 122 | response to host (GO:0075136) | 2.50554615 |
| 123 | response to host defenses (GO:0052200) | 2.50554615 |
| 124 | positive regulation of heat generation (GO:0031652) | 2.49089685 |
| 125 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.48692958 |
| 126 | amino sugar catabolic process (GO:0046348) | 2.47097965 |
| 127 | regulation of lymphocyte migration (GO:2000401) | 2.46429587 |
| 128 | leukotriene metabolic process (GO:0006691) | 2.46011250 |
| 129 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.44313609 |
| 130 | membrane protein ectodomain proteolysis (GO:0006509) | 2.43808341 |
| 131 | regulation of T cell migration (GO:2000404) | 2.43598651 |
| 132 | myeloid leukocyte activation (GO:0002274) | 2.43013576 |
| 133 | ferric iron transport (GO:0015682) | 2.42762107 |
| 134 | trivalent inorganic cation transport (GO:0072512) | 2.42762107 |
| 135 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.42758595 |
| 136 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.42233279 |
| 137 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.42100379 |
| 138 | NIK/NF-kappaB signaling (GO:0038061) | 2.41610374 |
| 139 | * response to thyroid hormone (GO:0097066) | 2.40961748 |
| 140 | cellular response to arsenic-containing substance (GO:0071243) | 2.40940295 |
| 141 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.40587147 |
| 142 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.40468485 |
| 143 | cellular copper ion homeostasis (GO:0006878) | 2.40238108 |
| 144 | negative regulation of interleukin-17 production (GO:0032700) | 2.40122557 |
| 145 | positive regulation of B cell differentiation (GO:0045579) | 2.39679358 |
| 146 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.39434672 |
| 147 | pentose-phosphate shunt (GO:0006098) | 2.39373723 |
| 148 | B cell mediated immunity (GO:0019724) | 2.39055619 |
| 149 | T cell migration (GO:0072678) | 2.38639347 |
| 150 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.37292291 |
| 151 | detection of external biotic stimulus (GO:0098581) | 2.37154408 |
| 152 | glucose 6-phosphate metabolic process (GO:0051156) | 2.35581331 |
| 153 | lysosome organization (GO:0007040) | 2.34782114 |
| 154 | lytic vacuole organization (GO:0080171) | 2.34782114 |
| 155 | positive regulation of extracellular matrix organization (GO:1903055) | 2.32071267 |
| 156 | * skin morphogenesis (GO:0043589) | 2.31568053 |
| 157 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.30577461 |
| 158 | glucosamine-containing compound catabolic process (GO:1901072) | 2.29948420 |
| 159 | glial cell migration (GO:0008347) | 2.27746832 |
| 160 | serine transport (GO:0032329) | 2.27333909 |
| 161 | cellular response to type I interferon (GO:0071357) | 2.26381837 |
| 162 | type I interferon signaling pathway (GO:0060337) | 2.26381837 |
| 163 | positive regulation of nuclease activity (GO:0032075) | 2.26087051 |
| 164 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.25428262 |
| 165 | response to progesterone (GO:0032570) | 2.25125603 |
| 166 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.24932867 |
| 167 | response to type I interferon (GO:0034340) | 2.23558628 |
| 168 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.23505142 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.49640173 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.85599675 |
| 3 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.58611190 |
| 4 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.38527754 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.31779941 |
| 6 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.18975758 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.14574120 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.05772652 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.94860353 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.88225165 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.86567762 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.83503624 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.81906112 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.56371516 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.43491930 |
| 16 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.21195825 |
| 17 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.19227601 |
| 18 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.18017479 |
| 19 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.10731452 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.02840812 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.01881143 |
| 22 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.97795012 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.97039634 |
| 24 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.95100003 |
| 25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.94572591 |
| 26 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.94482003 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93858876 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.91414512 |
| 29 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.89646614 |
| 30 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.86859762 |
| 31 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.82206243 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.81955349 |
| 33 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.79962904 |
| 34 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.75881956 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.69510343 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.69417941 |
| 37 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67091036 |
| 38 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.61953179 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60524197 |
| 40 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.60025732 |
| 41 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.59126996 |
| 42 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.57859572 |
| 43 | MYB_26560356_Chip-Seq_TH2_Human | 1.56649414 |
| 44 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56458647 |
| 45 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.55226567 |
| 46 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.50208093 |
| 47 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.49840467 |
| 48 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.48977183 |
| 49 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.45964114 |
| 50 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.45587637 |
| 51 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.45371536 |
| 52 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.43974699 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.42576293 |
| 54 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.42044953 |
| 55 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41238757 |
| 56 | MAF_26560356_Chip-Seq_TH1_Human | 1.40841576 |
| 57 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.40314403 |
| 58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.40301488 |
| 59 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39807505 |
| 60 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.38361535 |
| 61 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36692251 |
| 62 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36525796 |
| 63 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34786613 |
| 64 | ATF3_27146783_Chip-Seq_COLON_Human | 1.34361837 |
| 65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34003325 |
| 66 | GATA1_22025678_ChIP-Seq_K562_Human | 1.32953362 |
| 67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.31573897 |
| 68 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31195701 |
| 69 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.30350707 |
| 70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.29938028 |
| 71 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.28205144 |
| 72 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.27850773 |
| 73 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27603248 |
| 74 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.27200861 |
| 75 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.27052068 |
| 76 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.26527724 |
| 77 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26294820 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25550510 |
| 79 | MYB_26560356_Chip-Seq_TH1_Human | 1.23028074 |
| 80 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.22701464 |
| 81 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22542516 |
| 82 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.21860832 |
| 83 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.21708096 |
| 84 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.21599296 |
| 85 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.21586984 |
| 86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21118829 |
| 87 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17893269 |
| 88 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.17677598 |
| 89 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17208853 |
| 90 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16129088 |
| 91 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.14194093 |
| 92 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14147898 |
| 93 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13367678 |
| 94 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.13355227 |
| 95 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.12634951 |
| 96 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.12233846 |
| 97 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11987865 |
| 98 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.10791652 |
| 99 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09749384 |
| 100 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.08094436 |
| 101 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.07651400 |
| 102 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.07399712 |
| 103 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.07377608 |
| 104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06689524 |
| 105 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05866536 |
| 106 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05251670 |
| 107 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03664688 |
| 108 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03063808 |
| 109 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02826920 |
| 110 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.02003787 |
| 111 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01759588 |
| 112 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01711674 |
| 113 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01631554 |
| 114 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.01445352 |
| 115 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.00527104 |
| 116 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.99753328 |
| 117 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.99670736 |
| 118 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.99591798 |
| 119 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.98927189 |
| 120 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.98745019 |
| 121 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98053383 |
| 122 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.98030920 |
| 123 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97433017 |
| 124 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.97117392 |
| 125 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.96624306 |
| 126 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96018827 |
| 127 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.95960198 |
| 128 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95391242 |
| 129 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.93516862 |
| 130 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.93320685 |
| 131 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91909803 |
| 132 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91909803 |
| 133 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.91588130 |
| 134 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.91588130 |
| 135 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.90604162 |
| 136 | MAF_26560356_Chip-Seq_TH2_Human | 0.88914999 |
| 137 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85535394 |
| 138 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85396306 |
| 139 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.84573081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.47399293 |
| 2 | MP0003436_decreased_susceptibility_to | 3.48535718 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.33334765 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.04489087 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 2.96663918 |
| 6 | MP0003172_abnormal_lysosome_physiology | 2.92492092 |
| 7 | MP0006082_CNS_inflammation | 2.86690542 |
| 8 | MP0002419_abnormal_innate_immunity | 2.86380121 |
| 9 | MP0009840_abnormal_foam_cell | 2.75004832 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.69315592 |
| 11 | MP0009785_altered_susceptibility_to | 2.59400679 |
| 12 | MP0003303_peritoneal_inflammation | 2.56245901 |
| 13 | MP0005025_abnormal_response_to | 2.35155390 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.32188679 |
| 15 | * MP0001533_abnormal_skeleton_physiology | 2.27316299 |
| 16 | MP0005387_immune_system_phenotype | 2.23789910 |
| 17 | MP0001790_abnormal_immune_system | 2.23789910 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.18485282 |
| 19 | MP0000685_abnormal_immune_system | 2.10672202 |
| 20 | MP0000604_amyloidosis | 2.04386459 |
| 21 | * MP0002723_abnormal_immune_serum | 1.99211675 |
| 22 | MP0001800_abnormal_humoral_immune | 1.95891819 |
| 23 | MP0003724_increased_susceptibility_to | 1.91622599 |
| 24 | MP0004947_skin_inflammation | 1.91266981 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.89928161 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 1.86660610 |
| 27 | MP0001819_abnormal_immune_cell | 1.85668724 |
| 28 | MP0002420_abnormal_adaptive_immunity | 1.85368244 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.84339408 |
| 30 | MP0002933_joint_inflammation | 1.84001819 |
| 31 | * MP0005671_abnormal_response_to | 1.80979465 |
| 32 | MP0005451_abnormal_body_composition | 1.77780126 |
| 33 | MP0005310_abnormal_salivary_gland | 1.76169177 |
| 34 | MP0002405_respiratory_system_inflammati | 1.65518212 |
| 35 | MP0003448_altered_tumor_morphology | 1.65059075 |
| 36 | MP0003690_abnormal_glial_cell | 1.62563302 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.62271365 |
| 38 | MP0002998_abnormal_bone_remodeling | 1.61461250 |
| 39 | MP0000343_altered_response_to | 1.58797172 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.58359089 |
| 41 | MP0001958_emphysema | 1.57205864 |
| 42 | MP0001542_abnormal_bone_strength | 1.54557425 |
| 43 | MP0002877_abnormal_melanocyte_morpholog | 1.51260805 |
| 44 | MP0001853_heart_inflammation | 1.46002355 |
| 45 | MP0005275_abnormal_skin_tensile | 1.44431844 |
| 46 | MP0010234_abnormal_vibrissa_follicle | 1.43175515 |
| 47 | MP0000920_abnormal_myelination | 1.43055466 |
| 48 | * MP0008469_abnormal_protein_level | 1.41933308 |
| 49 | MP0006054_spinal_hemorrhage | 1.41839688 |
| 50 | MP0004272_abnormal_basement_membrane | 1.41131436 |
| 51 | MP0002139_abnormal_hepatobiliary_system | 1.39912787 |
| 52 | MP0003300_gastrointestinal_ulcer | 1.39328601 |
| 53 | MP0003566_abnormal_cell_adhesion | 1.38373911 |
| 54 | MP0000858_altered_metastatic_potential | 1.36913143 |
| 55 | * MP0005390_skeleton_phenotype | 1.36049617 |
| 56 | MP0004510_myositis | 1.33190682 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.28665737 |
| 58 | MP0003075_altered_response_to | 1.28151320 |
| 59 | * MP0000716_abnormal_immune_system | 1.27088178 |
| 60 | MP0005408_hypopigmentation | 1.22922901 |
| 61 | MP0003950_abnormal_plasma_membrane | 1.22867948 |
| 62 | MP0004233_abnormal_muscle_weight | 1.22347855 |
| 63 | MP0001851_eye_inflammation | 1.22243384 |
| 64 | MP0000015_abnormal_ear_pigmentation | 1.22084479 |
| 65 | MP0005164_abnormal_response_to | 1.22059771 |
| 66 | MP0005023_abnormal_wound_healing | 1.21329728 |
| 67 | MP0010155_abnormal_intestine_physiology | 1.21093277 |
| 68 | MP0000371_diluted_coat_color | 1.17301951 |
| 69 | MP0003195_calcinosis | 1.17212026 |
| 70 | MP0005165_increased_susceptibility_to | 1.16040477 |
| 71 | MP0009764_decreased_sensitivity_to | 1.14966617 |
| 72 | MP0001849_ear_inflammation | 1.14542650 |
| 73 | MP0003705_abnormal_hypodermis_morpholog | 1.12688569 |
| 74 | MP0004858_abnormal_nervous_system | 1.10908280 |
| 75 | MP0002254_reproductive_system_inflammat | 1.10597891 |
| 76 | * MP0003795_abnormal_bone_structure | 1.10143328 |
| 77 | * MP0002398_abnormal_bone_marrow | 1.09854881 |
| 78 | MP0003329_amyloid_beta_deposits | 1.09484067 |
| 79 | MP0002166_altered_tumor_susceptibility | 1.08497587 |
| 80 | * MP0000689_abnormal_spleen_morphology | 1.08113275 |
| 81 | MP0003186_abnormal_redox_activity | 1.06110028 |
| 82 | * MP0002429_abnormal_blood_cell | 1.05095559 |
| 83 | MP0002896_abnormal_bone_mineralization | 1.03208937 |
| 84 | MP0002006_tumorigenesis | 1.02932648 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 1.02089341 |
| 86 | MP0005365_abnormal_bile_salt | 0.98985202 |
| 87 | MP0005257_abnormal_intraocular_pressure | 0.97764263 |
| 88 | * MP0002722_abnormal_immune_system | 0.96881189 |
| 89 | MP0003279_aneurysm | 0.93944938 |
| 90 | MP0003091_abnormal_cell_migration | 0.93535013 |
| 91 | MP0001243_abnormal_dermal_layer | 0.93248426 |
| 92 | MP0008260_abnormal_autophagy | 0.90779566 |
| 93 | MP0008004_abnormal_stomach_pH | 0.89303125 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 0.89073918 |
| 95 | MP0000681_abnormal_thyroid_gland | 0.87987639 |
| 96 | MP0005171_absent_coat_pigmentation | 0.86372937 |
| 97 | MP0009384_cardiac_valve_regurgitation | 0.84854783 |
| 98 | MP0003828_pulmonary_edema | 0.84008533 |
| 99 | MP0010352_gastrointestinal_tract_polyps | 0.83434237 |
| 100 | MP0002060_abnormal_skin_morphology | 0.82153401 |
| 101 | MP0000767_abnormal_smooth_muscle | 0.81315526 |
| 102 | MP0000249_abnormal_blood_vessel | 0.77089695 |
| 103 | MP0005508_abnormal_skeleton_morphology | 0.75751042 |
| 104 | MP0010386_abnormal_urinary_bladder | 0.75435765 |
| 105 | MP0005503_abnormal_tendon_morphology | 0.74610034 |
| 106 | MP0005623_abnormal_meninges_morphology | 0.74474918 |
| 107 | MP0004883_abnormal_blood_vessel | 0.73772861 |
| 108 | MP0005166_decreased_susceptibility_to | 0.73610130 |
| 109 | MP0005174_abnormal_tail_pigmentation | 0.72448183 |
| 110 | * MP0002295_abnormal_pulmonary_circulatio | 0.71590324 |
| 111 | MP0009763_increased_sensitivity_to | 0.71465915 |
| 112 | MP0001873_stomach_inflammation | 0.71275492 |
| 113 | * MP0005319_abnormal_enzyme/_coenzyme | 0.70847179 |
| 114 | MP0004782_abnormal_surfactant_physiolog | 0.70113501 |
| 115 | MP0002796_impaired_skin_barrier | 0.69061083 |
| 116 | * MP0001216_abnormal_epidermal_layer | 0.68497158 |
| 117 | * MP0003634_abnormal_glial_cell | 0.68189791 |
| 118 | MP0002136_abnormal_kidney_physiology | 0.68061484 |
| 119 | MP0000490_abnormal_crypts_of | 0.66891528 |
| 120 | MP0009643_abnormal_urine_homeostasis | 0.66588098 |
| 121 | MP0010307_abnormal_tumor_latency | 0.66481685 |
| 122 | MP0009278_abnormal_bone_marrow | 0.65580703 |
| 123 | MP0001545_abnormal_hematopoietic_system | 0.64273148 |
| 124 | MP0005397_hematopoietic_system_phenotyp | 0.64273148 |
| 125 | MP0005595_abnormal_vascular_smooth | 0.63335832 |
| 126 | MP0000372_irregular_coat_pigmentation | 0.62879594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.85847545 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 5.52530252 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.24413185 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 5.22514085 |
| 5 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.96777121 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.96336817 |
| 7 | Dysostosis multiplex (HP:0000943) | 4.95372461 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.48545842 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.96809104 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 3.88468004 |
| 11 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.81002658 |
| 12 | Mucopolysacchariduria (HP:0008155) | 3.81002658 |
| 13 | Nuclear cataract (HP:0100018) | 3.68331773 |
| 14 | * Abnormality of glycolipid metabolism (HP:0010969) | 3.48772150 |
| 15 | * Abnormality of liposaccharide metabolism (HP:0010968) | 3.48772150 |
| 16 | * Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.48772150 |
| 17 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.46944202 |
| 18 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.46944202 |
| 19 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.46944202 |
| 20 | Recurrent skin infections (HP:0001581) | 3.41656073 |
| 21 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.37097879 |
| 22 | Premature rupture of membranes (HP:0001788) | 3.28155626 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.21194242 |
| 24 | Obstructive lung disease (HP:0006536) | 3.02890443 |
| 25 | Chronic obstructive pulmonary disease (HP:0006510) | 3.02890443 |
| 26 | Axonal loss (HP:0003447) | 2.93797535 |
| 27 | Cervical subluxation (HP:0003308) | 2.91603036 |
| 28 | Osteolytic defects of the hand bones (HP:0009699) | 2.88029832 |
| 29 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.88029832 |
| 30 | Gingivitis (HP:0000230) | 2.84421800 |
| 31 | Hepatosplenomegaly (HP:0001433) | 2.81730783 |
| 32 | Loss of speech (HP:0002371) | 2.78886895 |
| 33 | Stomatitis (HP:0010280) | 2.75949005 |
| 34 | Neurofibrillary tangles (HP:0002185) | 2.75717295 |
| 35 | Pustule (HP:0200039) | 2.72420251 |
| 36 | Mediastinal lymphadenopathy (HP:0100721) | 2.63460065 |
| 37 | Basal ganglia calcification (HP:0002135) | 2.58822192 |
| 38 | Recurrent fungal infections (HP:0002841) | 2.56744237 |
| 39 | Disinhibition (HP:0000734) | 2.55886794 |
| 40 | * Vertebral compression fractures (HP:0002953) | 2.49391063 |
| 41 | Parakeratosis (HP:0001036) | 2.47560851 |
| 42 | Myositis (HP:0100614) | 2.47221792 |
| 43 | Poor head control (HP:0002421) | 2.41978228 |
| 44 | Recurrent viral infections (HP:0004429) | 2.41406804 |
| 45 | Urticaria (HP:0001025) | 2.40473947 |
| 46 | Cellulitis (HP:0100658) | 2.37305761 |
| 47 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.37253648 |
| 48 | Glomerulonephritis (HP:0000099) | 2.36621668 |
| 49 | Beaking of vertebral bodies (HP:0004568) | 2.34930086 |
| 50 | Abnormality of the lumbar spine (HP:0100712) | 2.32775277 |
| 51 | Chronic otitis media (HP:0000389) | 2.30986676 |
| 52 | Distal lower limb muscle weakness (HP:0009053) | 2.29223615 |
| 53 | Prolonged neonatal jaundice (HP:0006579) | 2.28393410 |
| 54 | Amyloidosis (HP:0011034) | 2.28118950 |
| 55 | Autoimmune thrombocytopenia (HP:0001973) | 2.27143744 |
| 56 | Periodontitis (HP:0000704) | 2.26519034 |
| 57 | Thick nail (HP:0001805) | 2.25734317 |
| 58 | Spondylolisthesis (HP:0003302) | 2.25651673 |
| 59 | Short nail (HP:0001799) | 2.24666928 |
| 60 | * Progressive neurologic deterioration (HP:0002344) | 2.24271146 |
| 61 | Ankle contracture (HP:0006466) | 2.23130471 |
| 62 | Upper motor neuron abnormality (HP:0002127) | 2.21453856 |
| 63 | Epiphyseal dysplasia (HP:0002656) | 2.20547458 |
| 64 | Joint stiffness (HP:0001387) | 2.20366038 |
| 65 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.20311035 |
| 66 | Ovoid vertebral bodies (HP:0003300) | 2.14106713 |
| 67 | * Cardiomegaly (HP:0001640) | 2.13900641 |
| 68 | Peritonitis (HP:0002586) | 2.13234226 |
| 69 | Osteomyelitis (HP:0002754) | 2.12712642 |
| 70 | Myocardial infarction (HP:0001658) | 2.12025787 |
| 71 | Achilles tendon contracture (HP:0001771) | 2.10861917 |
| 72 | * Petechiae (HP:0000967) | 2.08991741 |
| 73 | Recurrent pneumonia (HP:0006532) | 2.06886134 |
| 74 | * Interstitial pulmonary disease (HP:0006530) | 2.03323297 |
| 75 | Cerebral aneurysm (HP:0004944) | 2.00934638 |
| 76 | Upper limb amyotrophy (HP:0009129) | 2.00254216 |
| 77 | Distal upper limb amyotrophy (HP:0007149) | 2.00254216 |
| 78 | Asymmetric septal hypertrophy (HP:0001670) | 1.99928663 |
| 79 | Vasculitis (HP:0002633) | 1.96951858 |
| 80 | * Purpura (HP:0000979) | 1.96833875 |
| 81 | Small epiphyses (HP:0010585) | 1.96671819 |
| 82 | Abnormality of the Achilles tendon (HP:0005109) | 1.95678723 |
| 83 | Abnormality of complement system (HP:0005339) | 1.95590492 |
| 84 | Emphysema (HP:0002097) | 1.95161747 |
| 85 | Hypoplasia of the odontoid process (HP:0003311) | 1.94710392 |
| 86 | * Bone pain (HP:0002653) | 1.94650865 |
| 87 | Tetraparesis (HP:0002273) | 1.92979640 |
| 88 | Leukocytosis (HP:0001974) | 1.92858554 |
| 89 | Increased IgE level (HP:0003212) | 1.91772023 |
| 90 | Personality changes (HP:0000751) | 1.91519663 |
| 91 | Blue sclerae (HP:0000592) | 1.89341797 |
| 92 | Thoracic kyphosis (HP:0002942) | 1.89051085 |
| 93 | Neuronal loss in central nervous system (HP:0002529) | 1.87541809 |
| 94 | Orchitis (HP:0100796) | 1.85842452 |
| 95 | J-shaped sella turcica (HP:0002680) | 1.85123818 |
| 96 | Elbow flexion contracture (HP:0002987) | 1.83864375 |
| 97 | * Pathologic fracture (HP:0002756) | 1.82902135 |
| 98 | Mutism (HP:0002300) | 1.82712295 |
| 99 | Eosinophilia (HP:0001880) | 1.82035916 |
| 100 | Recurrent lower respiratory tract infections (HP:0002783) | 1.81267808 |
| 101 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.79730441 |
| 102 | * Hypergammaglobulinemia (HP:0010702) | 1.78206754 |
| 103 | Cerebral inclusion bodies (HP:0100314) | 1.76884082 |
| 104 | Abnormality of the odontoid process (HP:0003310) | 1.76543317 |
| 105 | Neoplasm of head and neck (HP:0012288) | 1.76154408 |
| 106 | Esophageal neoplasm (HP:0100751) | 1.76154408 |
| 107 | Increased connective tissue (HP:0009025) | 1.75444363 |
| 108 | Cupped ribs (HP:0000887) | 1.75074166 |
| 109 | * Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.74842246 |
| 110 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.74317992 |
| 111 | Premature loss of primary teeth (HP:0006323) | 1.73420633 |
| 112 | Abnormality of the umbilical cord (HP:0010881) | 1.72856541 |
| 113 | Hand muscle atrophy (HP:0009130) | 1.72527774 |
| 114 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.72350289 |
| 115 | Recurrent cutaneous fungal infections (HP:0011370) | 1.72350289 |
| 116 | Dilatation of the ascending aorta (HP:0005111) | 1.71616676 |
| 117 | Distal lower limb amyotrophy (HP:0008944) | 1.70998694 |
| 118 | Follicular hyperkeratosis (HP:0007502) | 1.70625138 |
| 119 | Meningitis (HP:0001287) | 1.68701718 |
| 120 | Ocular albinism (HP:0001107) | 1.67578976 |
| 121 | Atrophic scars (HP:0001075) | 1.67560099 |
| 122 | Skin ulcer (HP:0200042) | 1.67111352 |
| 123 | Xanthomatosis (HP:0000991) | 1.66756786 |
| 124 | Vascular tortuosity (HP:0004948) | 1.66295899 |
| 125 | Rough bone trabeculation (HP:0100670) | 1.65686822 |
| 126 | Fragile skin (HP:0001030) | 1.65526179 |
| 127 | Complement deficiency (HP:0004431) | 1.65458878 |
| 128 | Wormian bones (HP:0002645) | 1.64324565 |
| 129 | * Congenital ichthyosiform erythroderma (HP:0007431) | 1.64259098 |
| 130 | Agnosia (HP:0010524) | 1.63974946 |
| 131 | Hyperacusis (HP:0010780) | 1.63599576 |
| 132 | Coxa vara (HP:0002812) | 1.63257603 |
| 133 | Anhidrosis (HP:0000970) | 1.63138205 |
| 134 | Protrusio acetabuli (HP:0003179) | 1.62563566 |
| 135 | Generalized amyotrophy (HP:0003700) | 1.61929450 |
| 136 | Bladder diverticulum (HP:0000015) | 1.61905180 |
| 137 | Increased serum ferritin (HP:0003281) | 1.61652896 |
| 138 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.60995451 |
| 139 | * Diminished motivation (HP:0000745) | 1.60278217 |
| 140 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.59230599 |
| 141 | Abnormality of the acetabulum (HP:0003170) | 1.57796435 |
| 142 | Genu recurvatum (HP:0002816) | 1.57548994 |
| 143 | Aneurysm (HP:0002617) | 1.57390205 |
| 144 | Aortic dissection (HP:0002647) | 1.57067032 |
| 145 | * Apathy (HP:0000741) | 1.56681588 |
| 146 | Deformed sella turcica (HP:0002681) | 1.56184802 |
| 147 | Thin bony cortex (HP:0002753) | 1.55763676 |
| 148 | Zonular cataract (HP:0010920) | 1.55575802 |
| 149 | Hyperparathyroidism (HP:0000843) | 1.55522907 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.29885842 |
| 2 | IRAK4 | 3.26960607 |
| 3 | ERN1 | 3.25212945 |
| 4 | MAP3K14 | 3.12696805 |
| 5 | IRAK3 | 2.99368887 |
| 6 | TYK2 | 2.79608201 |
| 7 | TBK1 | 2.78662098 |
| 8 | EPHB1 | 2.63369622 |
| 9 | NME2 | 2.62298116 |
| 10 | PIM2 | 2.45604356 |
| 11 | KIT | 2.35908825 |
| 12 | MAP4K1 | 2.29334878 |
| 13 | PBK | 2.20507164 |
| 14 | MST4 | 1.95769879 |
| 15 | TAOK2 | 1.85126306 |
| 16 | IKBKB | 1.80989428 |
| 17 | SIK1 | 1.80095916 |
| 18 | ZAP70 | 1.79790706 |
| 19 | TESK2 | 1.68988447 |
| 20 | IKBKE | 1.65481790 |
| 21 | RIPK4 | 1.54822463 |
| 22 | MYLK | 1.51366295 |
| 23 | PRPF4B | 1.50407172 |
| 24 | RIPK1 | 1.49324072 |
| 25 | MAP3K12 | 1.46370587 |
| 26 | PTK2 | 1.45539481 |
| 27 | NEK9 | 1.44425453 |
| 28 | LRRK2 | 1.41192974 |
| 29 | STK10 | 1.41120722 |
| 30 | JAK1 | 1.40394386 |
| 31 | CSF1R | 1.38068686 |
| 32 | PRKD2 | 1.36617475 |
| 33 | JAK3 | 1.35884890 |
| 34 | CSK | 1.35707942 |
| 35 | PDGFRA | 1.35585491 |
| 36 | EIF2AK3 | 1.33750404 |
| 37 | MET | 1.33331972 |
| 38 | TRPM7 | 1.30487824 |
| 39 | TAOK1 | 1.28233111 |
| 40 | GRK7 | 1.26302320 |
| 41 | TXK | 1.26120985 |
| 42 | MST1R | 1.22113031 |
| 43 | SMG1 | 1.19159213 |
| 44 | HCK | 1.18121561 |
| 45 | BTK | 1.16409418 |
| 46 | CDC42BPA | 1.14612126 |
| 47 | ARAF | 1.13627951 |
| 48 | TAOK3 | 1.13509775 |
| 49 | SIK3 | 1.13368389 |
| 50 | TGFBR2 | 1.12409877 |
| 51 | SYK | 1.11495744 |
| 52 | MAP3K13 | 1.09522729 |
| 53 | ITK | 1.09285207 |
| 54 | MAP3K1 | 1.08690523 |
| 55 | ABL2 | 1.08395712 |
| 56 | LYN | 1.08293353 |
| 57 | EIF2AK1 | 1.07560930 |
| 58 | PAK4 | 1.07450602 |
| 59 | MAPKAPK3 | 1.04537632 |
| 60 | SCYL2 | 1.04051219 |
| 61 | PIK3CG | 1.04006438 |
| 62 | BMX | 1.00730718 |
| 63 | ICK | 1.00600038 |
| 64 | TEC | 1.00116864 |
| 65 | LCK | 0.97749023 |
| 66 | TESK1 | 0.97082549 |
| 67 | IRAK1 | 0.93736059 |
| 68 | MAPKAPK5 | 0.93021222 |
| 69 | NTRK1 | 0.92443302 |
| 70 | STK38 | 0.87026915 |
| 71 | RPS6KA4 | 0.86305083 |
| 72 | MAP3K3 | 0.85708064 |
| 73 | EPHA3 | 0.85010072 |
| 74 | TRIB3 | 0.83834974 |
| 75 | FGFR4 | 0.82020642 |
| 76 | LMTK2 | 0.80056646 |
| 77 | MAP3K2 | 0.78694346 |
| 78 | TTN | 0.77358621 |
| 79 | DDR2 | 0.76936560 |
| 80 | FES | 0.76162025 |
| 81 | CHUK | 0.74810037 |
| 82 | FGR | 0.73537131 |
| 83 | PDPK1 | 0.72799094 |
| 84 | CLK1 | 0.71297744 |
| 85 | PIM1 | 0.69722476 |
| 86 | JAK2 | 0.69493507 |
| 87 | MAP2K2 | 0.68869511 |
| 88 | EPHA2 | 0.68498993 |
| 89 | EPHB2 | 0.66513076 |
| 90 | PRKCD | 0.65694264 |
| 91 | LIMK1 | 0.65190535 |
| 92 | MAPKAPK2 | 0.62914933 |
| 93 | PRKCQ | 0.60732219 |
| 94 | MOS | 0.60268193 |
| 95 | RPS6KA2 | 0.58549875 |
| 96 | MAP2K3 | 0.58423538 |
| 97 | PKN2 | 0.58265691 |
| 98 | ABL1 | 0.58004496 |
| 99 | PTK6 | 0.55311986 |
| 100 | MATK | 0.55219241 |
| 101 | MAP3K11 | 0.54911248 |
| 102 | KDR | 0.54707836 |
| 103 | KSR2 | 0.53349056 |
| 104 | MAP3K6 | 0.53092784 |
| 105 | FER | 0.51850066 |
| 106 | MAP3K8 | 0.51506204 |
| 107 | STK16 | 0.51498105 |
| 108 | EGFR | 0.51013597 |
| 109 | MARK3 | 0.49748606 |
| 110 | MAPK15 | 0.49286772 |
| 111 | FLT3 | 0.48861774 |
| 112 | PAK1 | 0.44839068 |
| 113 | PDGFRB | 0.43834506 |
| 114 | LATS2 | 0.43644374 |
| 115 | CAMKK2 | 0.42792129 |
| 116 | DAPK3 | 0.42454916 |
| 117 | BMPR1B | 0.40883878 |
| 118 | RPS6KA5 | 0.40756944 |
| 119 | PAK6 | 0.39905347 |
| 120 | STK39 | 0.39171554 |
| 121 | CAMK2G | 0.37590922 |
| 122 | MAPK11 | 0.37508218 |
| 123 | DAPK1 | 0.36529741 |
| 124 | MAP2K6 | 0.36002126 |
| 125 | ERBB3 | 0.34731802 |
| 126 | GSK3A | 0.33833585 |
| 127 | TNIK | 0.33135076 |
| 128 | IRAK2 | 0.32688958 |
| 129 | GRK6 | 0.31258576 |
| 130 | STK4 | 0.31054928 |
| 131 | PRKG2 | 0.30291631 |
| 132 | FYN | 0.30188699 |
| 133 | PAK2 | 0.29957044 |
| 134 | STK24 | 0.28045502 |
| 135 | EIF2AK2 | 0.27807723 |
| 136 | MAPK4 | 0.27216586 |
| 137 | ILK | 0.26940362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Lysosome_Homo sapiens_hsa04142 | 3.56791617 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.95456226 |
| 3 | * Other glycan degradation_Homo sapiens_hsa00511 | 2.70781518 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.69962152 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.67555790 |
| 6 | Phagosome_Homo sapiens_hsa04145 | 2.23342021 |
| 7 | Malaria_Homo sapiens_hsa05144 | 2.21872802 |
| 8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.11802076 |
| 9 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.05360588 |
| 10 | Protein export_Homo sapiens_hsa03060 | 1.99688949 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.96066597 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.95744443 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.89765608 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 1.87569887 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.86446197 |
| 16 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.86203750 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.85819079 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.85054204 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.82612697 |
| 20 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.78021054 |
| 21 | Proteasome_Homo sapiens_hsa03050 | 1.75374713 |
| 22 | * Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.61715423 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.51673484 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.49139548 |
| 25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.45864441 |
| 26 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.45020910 |
| 27 | Measles_Homo sapiens_hsa05162 | 1.44497711 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.44115708 |
| 29 | Bladder cancer_Homo sapiens_hsa05219 | 1.43921192 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.42707349 |
| 31 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.42565002 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.37968260 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.37432705 |
| 34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.35658259 |
| 35 | Allograft rejection_Homo sapiens_hsa05330 | 1.33550905 |
| 36 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.29754499 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.27688133 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.27611651 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.23194339 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22935762 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.20619731 |
| 42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.16979323 |
| 43 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.16782243 |
| 44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15373369 |
| 45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.13882001 |
| 46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.11421833 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.04190112 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01719588 |
| 49 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01682638 |
| 50 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.00138848 |
| 51 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.99418049 |
| 52 | Influenza A_Homo sapiens_hsa05164 | 0.95883752 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.95755756 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.95255896 |
| 55 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.92022212 |
| 56 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.90546847 |
| 57 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.89950643 |
| 58 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.88853480 |
| 59 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.86096742 |
| 60 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.84167325 |
| 61 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.82208292 |
| 62 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.81207793 |
| 63 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.80128022 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 0.77069313 |
| 65 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.76928856 |
| 66 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.76483702 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74835933 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.73619315 |
| 69 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.72746340 |
| 70 | Hepatitis C_Homo sapiens_hsa05160 | 0.72146862 |
| 71 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.72122460 |
| 72 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.71014359 |
| 73 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.69972463 |
| 74 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.69251187 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.68311777 |
| 76 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.68029503 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.66427774 |
| 78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65304999 |
| 79 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.63670564 |
| 80 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61608860 |
| 81 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.60343964 |
| 82 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59846057 |
| 83 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.59048439 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58757908 |
| 85 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.57673439 |
| 86 | Histidine metabolism_Homo sapiens_hsa00340 | 0.55225450 |
| 87 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55183249 |
| 88 | Viral myocarditis_Homo sapiens_hsa05416 | 0.54640946 |
| 89 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.54253001 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52964640 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.52247509 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51818342 |
| 93 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51626842 |
| 94 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.51610733 |
| 95 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.51270993 |
| 96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50794330 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50708240 |
| 98 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.50476788 |
| 99 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50388099 |
| 100 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49744897 |
| 101 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.49496955 |
| 102 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.49354746 |
| 103 | Mineral absorption_Homo sapiens_hsa04978 | 0.49256442 |
| 104 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.49123080 |
| 105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47692521 |
| 106 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.46012686 |
| 107 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45486498 |
| 108 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45242166 |
| 109 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44375958 |
| 110 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.44013190 |
| 111 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43748731 |
| 112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.43265714 |
| 113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43234418 |
| 114 | Platelet activation_Homo sapiens_hsa04611 | 0.42853477 |
| 115 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.42564234 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.41357121 |
| 117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41326880 |
| 118 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.41064971 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39665201 |
| 120 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38131082 |
| 121 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37507962 |
| 122 | Sulfur relay system_Homo sapiens_hsa04122 | 0.35493822 |
| 123 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.32200179 |
| 124 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31658551 |

